Drugs Made In America Acquisition Ordinary Shares Other Current Assets

The latest other current assets for DMAA is $49K as of June 2026. That compares with $49K in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Drugs Made In America Acquisition Ordinary Shares's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAA's other current assets moved from $49K to $49K — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Drugs Made In America Acquisition Ordinary Shares's operating scale or balance-sheet position.

A other current assets figure of $49K for DMAA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAA's other current assets ($49K), review year-over-year change from $49K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.